Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan J Reshkin

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta|August 16, 2005
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single natureSalvador Harguindey, Gorka Orive, José Luis Pedraz, et al.
Current Alzheimer Research|February 24, 2007
Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangersSalvador Harguindey, Stephan J Reshkin, Gorka Orive, et al.
Biochimica Et Biophysica Acta|February 5, 2013
The role of proton dynamics in the development and maintenance of multidrug resistance in cancerChloë Daniel, Charlotte Bell, Christopher Burton, et al.
International Journal of Molecular Medicine|June 7, 2003
ErbB2 and the antimetastatic nm23/NDP kinase in regulating serum induced breast cancer invasionStefania Tommasi, Vita Fedele, Antonella Crapolicchio, et al.
Biochimica Et Biophysica Acta|August 8, 2006
The complexity of targeting EGFR signalling in cancer: from expression to turnoverSinto Sebastian, Jeffrey Settleman, Stephan J Reshkin, et al.
Anticancer Research|June 17, 2009
Proton transport inhibitors as potentially selective anticancer drugsSalvador Harguindey, Jose Luis Arranz, Miriam L Wahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cellsStephan J Reshkin, Antonia Bellizzi, Rosa Angela Cardone, et al.
European Journal of Cell Biology|March 11, 2008
Protons extruded by NHE1: digestive or glue?Christian Stock, Rosa Angela Cardone, Giovanni Busco, et al.
Oncology Reports|August 9, 2002
Gonadotropin releasing hormone receptor expression in primary breast cancer: comparison of immunohistochemical, radioligand and Western blot analysesAnita Mangia, Stefania Tommasi, Stephan J Reshkin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 14, 2021
The possible role of methylglyoxal metabolism in cancerKhalid O Alfarouk, Saad S Alqahtani, Saeed Alshahrani, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta|August 16, 2005
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single natureSalvador Harguindey, Gorka Orive, José Luis Pedraz, et al.
Current Alzheimer Research|February 24, 2007
Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangersSalvador Harguindey, Stephan J Reshkin, Gorka Orive, et al.
Biochimica Et Biophysica Acta|February 5, 2013
The role of proton dynamics in the development and maintenance of multidrug resistance in cancerChloë Daniel, Charlotte Bell, Christopher Burton, et al.
International Journal of Molecular Medicine|June 7, 2003
ErbB2 and the antimetastatic nm23/NDP kinase in regulating serum induced breast cancer invasionStefania Tommasi, Vita Fedele, Antonella Crapolicchio, et al.
Biochimica Et Biophysica Acta|August 8, 2006
The complexity of targeting EGFR signalling in cancer: from expression to turnoverSinto Sebastian, Jeffrey Settleman, Stephan J Reshkin, et al.
Anticancer Research|June 17, 2009
Proton transport inhibitors as potentially selective anticancer drugsSalvador Harguindey, Jose Luis Arranz, Miriam L Wahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cellsStephan J Reshkin, Antonia Bellizzi, Rosa Angela Cardone, et al.
European Journal of Cell Biology|March 11, 2008
Protons extruded by NHE1: digestive or glue?Christian Stock, Rosa Angela Cardone, Giovanni Busco, et al.
Oncology Reports|August 9, 2002
Gonadotropin releasing hormone receptor expression in primary breast cancer: comparison of immunohistochemical, radioligand and Western blot analysesAnita Mangia, Stefania Tommasi, Stephan J Reshkin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 14, 2021
The possible role of methylglyoxal metabolism in cancerKhalid O Alfarouk, Saad S Alqahtani, Saeed Alshahrani, et al.
Pageof 6